Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;92(11):2322-2324.
doi: 10.1002/jmv.26004. Epub 2020 May 22.

Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19

Affiliations
Comment

Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19

Vui Heng Chong et al. J Med Virol. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All the authors declare that there are no conflict of interests.

Comment on

References

    1. Sarma P, Kaur H, Kumar H, et al. Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: a systematic review and meta‐analysis [published online ahead of print April 16, 2020]. J Med Virol. 2020. 10.1002/jmv.25898 - DOI - PMC - PubMed
    1. Jaffe S. Regulators split on antimalarials for COVID‐19. Lancet. 2020;395(10231):1179. 10.1016/S0140-6736(20)30817-5 - DOI - PMC - PubMed
    1. Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID‐19: the need for an evidence base [published online ahead of print April 15, 2020]. Lancet Respir Med. 2020. 10.1016/S2213-2600(20)30172-7 - DOI - PMC - PubMed
    1. Molina JM, Delaugerre C, Le Goff J, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID‐19 infection [published online ahead of print March 30, 2020]. Med Mal Infect. 2020. 10.1016/j.medmal.2020.03.006 - DOI - PMC - PubMed
    1. Chorin E, Matthew D, Shulman E. The QT interval in patients with SARS‐CoV‐2 infection treated with hydroxychloroquine/azithromycin [published online ahead of print April 03, 2020]. medrxiv. 10.1101/2020.04.02.20047050 - DOI